Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2005  |  Volume : 1  |  Issue : 1  |  Page : 38-40

A phase I trial of tocoferol monoglucoside in patients undergoing hemi-body radiation

1 Division of Radiation Oncology, Nanavati Hospital, Vile Parle (W), Mumbai, India
2 Radiation Biochemistry Section, Radiation Biology and Health Science Division, BARC, Anushaktinagar, Mumbai, India
3 Kinki Invention Center, Yoshida Kawahara.cho 14, Sakyo-ku, Kyoyo - 606 8305, Japan

Correspondence Address:
N G Huilgol
Division of Radiation Oncology, Nanavati Hospital, Vile Parle (W), Mumbai
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-1482.16089

Rights and Permissions

Purpose: To evaluate Tocoferol monoglucoside (TMG), a water soluble vit. E. in a phase I trial, as a radiation protector in those undergoing hemi-body radiation for disseminated disease. Materials and Methods: Patients scheduled to receive modified hemi-body radiation were accrued for the study. Patients not only had disseminated skeletal disease but, were heavily pretreated Seven patients were accrued for the study. Patients received 1 and 2 gms of TMG. 30-40 minutes before hemibody radiation. A dose of 600 cGy was delivered on telecobalt equipment at mid plane. Immediate Toxicities were evaluated as well as response to pain. Results: All the seven patients underwent radiation uneventfully. There was no drug related toxicity. Pain relief was adequate. Conclusion: Tocoferol monoglucoside an effective antioxidant with no significant acute toxicity, when administered in a dose of 1 or 2 gms per oral route. TMG being water-soluble can have global antioxidant and radio protective effects. This needs further clinical evaluation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded360    
    Comments [Add]    
    Cited by others 5    

Recommend this journal